November 18, 2026 · BJOG : an international journal of obstetrics and gynaecology · DOI: 10.1111/1471-0528.70381

Injectable Hyaluronic Acid for Genitourinary Syndrome of Menopause.

Listen to this summary

This narrative review asks whether local, non-hormonal treatments, particularly injectable hyaluronic acid, can help women with genitourinary syndrome of menopause who cannot or will not use vaginal oestrogen. The authors report that injectable hybrid cooperative complex hyaluronic acid (HCC-HA) shows potential benefit for vaginal dryness and dyspareunia in small studies and one randomised trial (conducted in women with sexual dysfunction rather than strictly defined GSM), with no serious adverse events reported. However, they conclude that evidence is not yet sufficient to make these therapies routine or guideline-recommended, and that larger independent trials with longer follow-up are needed.

Marco Menabrito, Joaquim Calaf

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play